Form 4: Pulmonx Director Daniel Florin Receives RSU Grant

Director Daniel P. Florin was granted 40,000 restricted stock units in Pulmonx Corporation.

Summary

• Director Daniel P. Florin acquired 40,000 restricted stock units (RSUs) on June 5, 2026.
• The RSUs represent a right to receive common stock of Pulmonx Corporation.
• Following this transaction, the director's total beneficial ownership of common stock increased to 133,910 shares.
• The grant was issued at a price of $0 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• Potential future dilution for existing shareholders upon the vesting and issuance of the underlying common stock.

Risks

• Market volatility affecting the future value of the equity grant.
• Dependence on the company's ability to meet performance or tenure requirements for vesting.

Future Outlook

The RSUs vest on the earlier of the one-year anniversary of the grant date (June 5, 2027) or the date of the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the medical device sector to ensure long-term alignment with shareholder interests.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices for mid-cap medical technology companies.
• Vesting schedules tied to annual meetings are common among publicly traded life sciences firms.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor dilution impact upon future vesting.
• Director: Increased equity stake in the company.

Next Steps

• Vesting of the 40,000 RSUs on or before June 5, 2027.

Key Dates

Keywords

Pulmonx, LUNG, Form 4, Insider Trading, Director Compensation, Restricted Stock Units